Karvezide

Irbesartan and Hydrochlorothiazide, the active ingredients in Karvezide, are an angiotensin II receptor blocker and a thiazide diuretic presented as tablets for oral use. They treat hypertension in adult patients by lowering blood pressure and reducing cardiovascular risk.

GNH USA supplies Karvezide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable logistics for global distribution. The company adheres to stringent manufacturing standards and provides comprehensive support to healthcare providers across multiple regions.

Karvezide acts on the renin‑angiotensin‑aldosterone system and promotes diuresis to manage high blood pressure.

Hypertension: reduces systolic and diastolic blood pressure, helping achieve target levels. Essential hypertension: provides effective blood pressure control in primary hypertension. High blood pressure: lowers cardiovascular risk by maintaining normal pressure.

Karvezide may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Dizziness: light‑headedness especially after standing. - Increased urination: due to diuretic effect. - Electrolyte imbalance: low potassium or sodium levels.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, potentially airway obstruction. - Severe allergic reaction: rash, itching, difficulty breathing. - Acute kidney injury: sudden loss of kidney function.

When prescribing Karvezide, clinicians should consider several safety factors.

Renal impairment: monitor kidney function and adjust dose if needed. Electrolyte disturbances: check serum potassium and sodium regularly. Pregnancy: contraindicated (Category D) due to risk of fetal harm. Concomitant potassium‑sparing agents: avoid to prevent hyperkalemia. Gout: thiazide component may increase uric acid levels. Store at ambient temperature: keep in original packaging, protect from moisture and light.

Karvezide can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Potassium‑sparing diuretics: risk of dangerous hyperkalemia. - ACE inhibitors: additive effect on potassium and renal function. - Lithium: thiazide component can raise lithium levels, causing toxicity.

Moderate Interactions (Monitor Closely): - Other antihypertensives: may cause excessive blood pressure reduction. - CYP2C9 inhibitors (e.g., fluconazole): increase irbesartan plasma concentrations.